Skip to Content

Brimonidine Ophthalmic Dosage

Medically reviewed on April 9, 2018.

Applies to the following strengths: 0.2%; 0.15%; 0.1%

Usual Adult Dose for Intraocular Hypertension

1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart

Comments:
-This drug may be used concomitantly with other topical ophthalmic drugs.
-If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.

Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Usual Adult Dose for Glaucoma (Open Angle)

1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart

Comments:
-This drug may be used concomitantly with other topical ophthalmic drugs.
-If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.

Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Usual Pediatric Dose for Intraocular Hypertension

2 years or older:
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart

Comments:
-This drug may be used concomitantly with other topical ophthalmic drugs.
-If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.

Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Usual Pediatric Dose for Glaucoma (Open Angle)

2 years or older:
1 drop in the affected eye(s) 3 times per day, approximately 8 hours apart

Comments:
-This drug may be used concomitantly with other topical ophthalmic drugs.
-If more than one topical ophthalmic drug is being used, the products should be administered at least 5 minutes apart.

Use: To lower intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Renal Dose Adjustments

Renal impairment: Use with caution

Liver Dose Adjustments

Liver impairment: Use with caution

Precautions

Safety and efficacy have not been established in patients younger than 2 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Patient advice:
-Pressure should be applied to the tear duct immediately following administration of the drug.
-This drug may cause blurred and/or abnormal vision, fatigue and/or drowsiness, which may impair the ability to drive or operate machinery.
-To avoid contamination of the solution, the container should be kept tightly closed.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide